Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
Chronic lymphocytic leukemia patients with heterogeneously or fully methylated LPL promotor display longer time to treatment. [electronic resource] by
- Daugaard, Iben
- Hussmann, Dianna
- Kristensen, Louise
- Kristensen, Thomas
- Kjeldsen, Tina E
- Nyvold, Charlotte G
- Larsen, Thomas S
- Møller, Michael B
- Hansen, Lise Lotte
- Wojdacz, Tomasz K
Producer: 20190528
In:
Epigenomics vol. 10
Availability: No items available.
|
|
|
17.
|
FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures. [electronic resource] by
- Wong, Kah Keng
- Gascoyne, Duncan M
- Soilleux, Elizabeth J
- Lyne, Linden
- Spearman, Hayley
- Roncador, Giovanna
- Pedersen, Lars M
- Møller, Michael B
- Green, Tina M
- Banham, Alison H
Producer: 20180118
In:
Oncotarget vol. 7
Availability: No items available.
|
|
|
18.
|
High intratumoural galectin-1 expression predicts adverse outcome in ALK [electronic resource] by
- Holst, Johanne Marie
- Ludvigsen, Maja
- Hamilton-Dutoit, Stephen Jacques
- Bendix, Knud
- Plesner, Trine Lindhardt
- Nørgaard, Peter
- Møller, Michael B
- Steiniche, Torben
- Rabinovich, Gabriel A
- d'Amore, Francesco
- Pedersen, Martin Bjerregård
Producer: 20200214
In:
Hematological oncology vol. 38
Availability: No items available.
|
|
|
19.
|
Multiplex polymerase chain reaction-based prognostic models in diffuse large B-cell lymphoma patients treated with R-CHOP. [electronic resource] by
- Green, Tina M
- Jensen, Andreas K
- Holst, René
- Falgreen, Steffen
- Bøgsted, Martin
- de Stricker, Karin
- Plesner, Torben
- Mourits-Andersen, Torben
- Frederiksen, Mikael
- Johnsen, Hans E
- Pedersen, Lars M
- Møller, Michael B
Producer: 20170515
In:
British journal of haematology vol. 174
Availability: No items available.
|
|
|
20.
|
NF-κB p50 activation associated with immune dysregulation confers poorer survival for diffuse large B-cell lymphoma patients with wild-type p53. [electronic resource] by
- Cai, Qingqing
- Tu, Meifeng
- Xu-Monette, Zijun Y
- Sun, Ruifang
- Manyam, Ganiraju C
- Xu, Xiaolu
- Tzankov, Alexander
- Hsi, Eric D
- Møller, Michael B
- Medeiros, L Jeffrey
- Ok, Chi Young
- Young, Ken H
Producer: 20180320
In:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc vol. 30
Availability: No items available.
|